Cargando…
Organ preservation in rectal cancer – Challenges and future strategies
Neoadjuvant radiochemotherapy with subsequent total mesorectal excision is the standard of care for locally advanced rectal cancer. While this multimodal strategy has decreased local recurrences rates below 5%, long-term morbidities are considerable in terms of urinary, sexual or bowel functioning....
Autores principales: | Gani, C., Bonomo, P., Zwirner, K., Schroeder, C., Menegakis, A., Rödel, C., Zips, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893528/ https://www.ncbi.nlm.nih.gov/pubmed/29658007 http://dx.doi.org/10.1016/j.ctro.2017.02.002 |
Ejemplares similares
-
Organ Preservation in Rectal Cancer: The Patients' Perspective
por: Gani, Cihan, et al.
Publicado: (2019) -
Online MR guided dose escalated radiotherapy for organ preservation in distal rectal cancer
por: Boeke, Simon, et al.
Publicado: (2022) -
1.5 T MR-linac planning study to compare two different strategies of rectal boost irradiation
por: Bonomo, Pierluigi, et al.
Publicado: (2020) -
Neutrophil-to-Lymphocyte Ratio in Rectal Cancer—Novel Biomarker of Tumor Immunogenicity During Radiotherapy or Confounding Variable?
por: Braun, Lore Helene, et al.
Publicado: (2019) -
MR-Guided Radiotherapy for Rectal Cancer: Current Perspective on Organ Preservation
por: Boldrini, Luca, et al.
Publicado: (2021)